ask="2.95"
ask_size="200"
average_daily_volume="111677"
bid="N/A"
bid_size="N/A"
book_value="1.07"
change="+0.01"
change_from_200_day_moving_average="-0.28"
change_from_50_day_moving_average="0.02"
change_from_52_week_high="-4.19"
change_From_52_week_low="0.62"
change_in_percent="+0.80%"
close="1.58"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.01"
ebitda="-16.58M"
eps_estimate_current_year="-2.91"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.37"
ex_dividend_date="N/A"
float_shares="5083000"
high="1.61"
high_52_weeks="5.77"
last_trade_date="3/8/2017"
last_trade_price="1.58"
last_trade_size="287"
last_trade_time="3:59pm"
low="1.54"
low_52_weeks="0.96"
market_capitalization="18.47M"
moving_average_200_day="1.86"
moving_average_50_day="1.56"
name="PhaseRx
Inc."
notes="N/A"
one_year_target_price="10.00"
open="1.53"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-14.89%"
percent_change_from_50_day_moving_average="+1.30%"
percent_change_from_52_week_high="-72.61%"
percent_change_from_52_week_low="+64.58%"
previous_close="1.57"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.47"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="11690000"
short_ratio="0.23"
stock_exchange="NCM"
symbol="PZRX"
volume="20031"
weeks_range_52="0.96 - 5.77"
